Sec. 356z.75. Coverage during a generic drug shortage.
181 words·~1 min read·
/il/chapter-215/act-5/356z-75·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Sec. 356z.75. Coverage during a generic drug shortage.
(a)As used in this Section:
"Eligible prescription drug" means a prescription drug approved under 21 U.S.C. 355(c) that is not under patent.
"Generic drug" means a drug that is approved pursuant to an application referencing an eligible prescription drug that is submitted under subsection
(j)of Section 505 of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. 355(j).
"Unavailable" means being listed as Currently in Shortage or as a Discontinuation in the United States Food and Drug Administration's Drug Shortages Database. "Unavailable" does not include being listed as a Resolved Shortage in the United States Food and Drug Administration's Drug Shortages Database.
(b)If a generic drug or a therapeutic equivalent is unavailable due to a supply issue and dosage cannot be adjusted, a group or individual policy of accident and health insurance or a managed care plan that is amended, delivered, issued, or renewed after January 1, 2026 shall provide coverage for a brand name eligible prescription drug until supply of the generic drug or a therapeutic equivalent is available.